摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 6-(p-Methoxyphenyl)hex-2-enoat | 52244-68-5

中文名称
——
中文别名
——
英文名称
Ethyl 6-(p-Methoxyphenyl)hex-2-enoat
英文别名
ethyl (E)-6-(4-methoxyphenyl)hex-2-enoate
Ethyl 6-(p-Methoxyphenyl)hex-2-enoat化学式
CAS
52244-68-5
化学式
C15H20O3
mdl
——
分子量
248.322
InChiKey
JOOIONZRYHTJPY-SOFGYWHQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    18
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Ethyl 6-(p-Methoxyphenyl)hex-2-enoat二异丁基氢化铝 作用下, 以 甲苯 为溶剂, 反应 0.08h, 以90%的产率得到(2E)-6-(4-甲氧基苯基)-2-己烯-1-醇
    参考文献:
    名称:
    Hg(OTf)2-Catalyzed Arylene Cyclization
    摘要:
    Novel Hg(OTf)(2)-Catalyzed arylene cyclization was achieved with highly efficient catalytic turnover (up to 200 times). The reaction takes place via protonation of allylic hydroxyl group by in situ formed TfOH of an organomercuric intermediate to generate a cationic species. Subsequent smooth demercuration regenerates the catalyst.
    DOI:
    10.1021/ol800450x
  • 作为产物:
    描述:
    磷酰基乙酸三乙酯4-甲氧基苯丁醛 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 0.16h, 以85%的产率得到Ethyl 6-(p-Methoxyphenyl)hex-2-enoat
    参考文献:
    名称:
    Hg(OTf)2-Catalyzed Arylene Cyclization
    摘要:
    Novel Hg(OTf)(2)-Catalyzed arylene cyclization was achieved with highly efficient catalytic turnover (up to 200 times). The reaction takes place via protonation of allylic hydroxyl group by in situ formed TfOH of an organomercuric intermediate to generate a cationic species. Subsequent smooth demercuration regenerates the catalyst.
    DOI:
    10.1021/ol800450x
点击查看最新优质反应信息

文献信息

  • PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS
    申请人:Cano Ivan Collado
    公开号:US20090062358A1
    公开(公告)日:2009-03-05
    The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C 1 -C 8 alkyl, aryl-C 0-2 -alkyl, heteroaryl-C 0-2 -alkyl, C3-C6 cycloalkylaryl-C 0-2 -alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl and heteroaryl. X is a C 2 -C 5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH 2 ) n COOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C 1 -C 5 alkyl, C 1 -C 5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C 1 -C 5 alkyl, C 1 -C 5 alkoxy, C 3 -C 6 cycloalkyl, arylC 0 -C 4 alkyl and phenyl, or R3 and R4 are combined to form a C 3 -C 4 cycloalkyl.
    本发明涉及以下结构式所代表的化合物,以及其药学上可接受的盐、溶剂合物和水合物,其中,R1是C1-C8烷基、芳基-C0-2-烷基、杂芳基-C0-2-烷基、C3-C6环烷基芳基-C0-2-烷基或苯基的取代或未取代基团。W为O或S。R2为H或C1-C6烷基、C3-C6环烷基和杂芳基的取代或未取代基团。X为C2-C5烷基链,在链中的一个碳原子可以被O、NH或S取代。Y为C、O、S、NH或单键。此外,E为(CH2)nCOOH,其中n为0、1、2或3,或C(R3)(R4)A,其中A为酸性功能基团,如羧基、羧酰基取代或未取代的磺酰胺基、取代或未取代的四唑基。R3为H、饱和或不饱和的C1-C5烷基、C1-C5烷氧基。此外,R4为H、卤素、C1-C5烷基、C1-C5烷氧基、C3-C6环烷基、芳基C0-C4烷基和苯基的取代或未取代基团,或R3和R4结合形成C3-C4环烷基。
  • US7304062B2
    申请人:——
    公开号:US7304062B2
    公开(公告)日:2007-12-04
  • Hg(OTf)<sub>2</sub>-Catalyzed Arylene Cyclization
    作者:Kosuke Namba、Hirofumi Yamamoto、Ikuo Sasaki、Kumiko Mori、Hiroshi Imagawa、Mugio Nishizawa
    DOI:10.1021/ol800450x
    日期:2008.5.1
    Novel Hg(OTf)(2)-Catalyzed arylene cyclization was achieved with highly efficient catalytic turnover (up to 200 times). The reaction takes place via protonation of allylic hydroxyl group by in situ formed TfOH of an organomercuric intermediate to generate a cationic species. Subsequent smooth demercuration regenerates the catalyst.
查看更多